 Letter
From The Publisher
There has been a remarkable evolution of nanotechnology
and MEMS industries since we first examined the market in
our Nanotech/MEMS report (#T601) in January 2003. In many
ways akin to the evolution of the biotech industry, which
first had a history of stimulating interest (e.g., financial)
then tended to fall short of expectations and finally began
realizing its potential, the nanotech and MEMS industries
have in a few short years begun moving from hype to profit.
As testimony to the huge potential that many entrepreneurs
still envision, the number of companies active in a wide
spectrum of nanotech or MEMS applications continues to grow.
Importantly, the industry of nanotech in particular is maturing
with respect to understanding that the “industry” is
in fact an aggregate of many different technologies and applications
with only nanoscale consideration being the common thread.
Of course, much of the growth in medical nanotech and MEMS
(nanomedicine and micromedicine) can be attributed to the
general, sustained growth and development of nanotech and
MEMS technologies beyond medical applications. Our current
analysis, “Micro- and Nanomedicine” (#T625),
published in May 2006, is detailed at http://www.mediligence.com/rpt-t625.htm.
Patrick Driscoll
Publisher
|
